Home/Filings/4/0001061983-13-000025
4//SEC Filing

CYTOKINETICS INC 4

Accession 0001061983-13-000025

$CYTKCIK 0001061983operating

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 6:03 PM ET

Size

8.3 KB

Accession

0001061983-13-000025

Insider Transaction Report

Form 4
Period: 2013-09-03
WOLFF ANDREW A
SVP Clinical R&D, CMO
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2013-09-0314,5830 total
    Common Stock (14,583 underlying)
  • Exercise/Conversion

    Common Stock

    2013-09-03+14,58326,116 total
  • Tax Payment

    Common Stock

    2013-09-03$7.65/sh5,479$41,91420,637 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock.
  • [F2]Shares withheld by Issuer to cover taxes associated with settlement of Restricted Stock Units
  • [F3]The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013.

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeoperating

Related Parties

1
  • filerCIK 0001061983

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 6:03 PM ET
Size
8.3 KB